Skip to main content
Von Hippel-Lindau Syndrome (VHL)
Von Hippel-Lindau syndrome (VHL) is a rare genetic disease that causes tumors in certain areas of your body. People with VHL require lifelong monitoring to detect and treat tumors before severe complications occur.

Our von Hippel-Lindau Program, one of Stanford Health Care’s Neurogenetic Cancer Programs, brings together specialists from across Stanford Health Care to match your unique needs. This approach ensures you receive coordinated, personalized care and support to help you manage this complex condition.

Connect to Care

Understanding Von Hippel-Lindau Syndrome


Risk Factors


Make An Appointment

To request an appointment, call: 650-497-7777

Connect to Care

Why Choose Stanford?

View Treatment Options